Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2007 2
2009 1
2010 1
2012 1
2013 5
2014 8
2015 4
2016 6
2017 11
2018 13
2019 5
2020 14
2021 15
2022 14
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
MULTIPLE SCLEROSIS - RISK FACTORS.
Adamczyk-Sowa M, Gębka-Kępińska B, Kępiński M. Adamczyk-Sowa M, et al. Wiad Lek. 2020;73(12 cz 1):2677-2682. Wiad Lek. 2020. PMID: 33577489 Review.
Common pathomechanism of migraine and depression.
Wachowska K, Bliźniewska-Kowalska K, Sławek J, Adamczyk-Sowa M, Szulc A, Maes M, Kuan-Pin S, Gałecki P. Wachowska K, et al. Among authors: adamczyk sowa m. Psychiatr Pol. 2023 Apr 30;57(2):405-419. doi: 10.12740/PP/OnlineFirst/143982. Epub 2023 Apr 30. Psychiatr Pol. 2023. PMID: 36371736 Free article. Review. English, Polish.
Klotho protein in neurodegenerative disorders.
Torbus-Paluszczak M, Bartman W, Adamczyk-Sowa M. Torbus-Paluszczak M, et al. Among authors: adamczyk sowa m. Neurol Sci. 2018 Oct;39(10):1677-1682. doi: 10.1007/s10072-018-3496-x. Epub 2018 Jul 30. Neurol Sci. 2018. PMID: 30062646 Free PMC article. Review.
Immunosenescence and multiple sclerosis.
Adamczyk-Sowa M, Nowak-Kiczmer M, Jaroszewicz J, Berger T. Adamczyk-Sowa M, et al. Neurol Neurochir Pol. 2022;56(3):220-227. doi: 10.5603/PJNNS.a2022.0045. Epub 2022 Jun 23. Neurol Neurochir Pol. 2022. PMID: 35735245 Free article.
Headache in Multiple Sclerosis: A Narrative Review.
Adamczyk B, Morawiec N, Boczek S, Dańda K, Herba M, Spyra A, Sowa A, Szczygieł J, Adamczyk-Sowa M. Adamczyk B, et al. Among authors: adamczyk sowa m. Medicina (Kaunas). 2024 Mar 30;60(4):572. doi: 10.3390/medicina60040572. Medicina (Kaunas). 2024. PMID: 38674218 Free PMC article. Review.
Neurologic manifestations of COVID-19. Authors' reply.
Adamczyk-Sowa M, Jaroszewicz J. Adamczyk-Sowa M, et al. Pol Arch Intern Med. 2021 Feb 26;131(2):208-209. doi: 10.20452/pamw.15840. Epub 2021 Feb 26. Pol Arch Intern Med. 2021. PMID: 33641319 Free article. No abstract available.
The influence of sodium on pathophysiology of multiple sclerosis.
Zostawa J, Adamczyk J, Sowa P, Adamczyk-Sowa M. Zostawa J, et al. Among authors: adamczyk sowa m. Neurol Sci. 2017 Mar;38(3):389-398. doi: 10.1007/s10072-016-2802-8. Epub 2017 Jan 11. Neurol Sci. 2017. PMID: 28078565 Free PMC article. Review.
114 results